Imatinib mesylate, increased bone formation, and secondary hyperparathyroidism
- PMID: 17151376
- DOI: 10.1056/NEJMc062388
Imatinib mesylate, increased bone formation, and secondary hyperparathyroidism
Comment on
-
Altered bone and mineral metabolism in patients receiving imatinib mesylate.N Engl J Med. 2006 May 11;354(19):2006-13. doi: 10.1056/NEJMoa051140. N Engl J Med. 2006. PMID: 16687713
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources